Roth Capital Has Pessimistic Outlook of Allstate Q3 Earnings

The Allstate Co. (NYSE:ALL) – Roth Capital cut their Q3 2025 EPS estimates for shares of Allstate in a research report issued on Wednesday, October 30th. Roth Capital analyst H. Fong now forecasts that the insurance provider will post earnings of $4.07 per share for the quarter, down from their previous estimate of $4.42. The consensus estimate for Allstate’s current full-year earnings is $14.16 per share. Roth Capital also issued estimates for Allstate’s Q4 2025 earnings at $5.97 EPS, Q1 2026 earnings at $6.41 EPS, Q2 2026 earnings at $3.46 EPS, Q3 2026 earnings at $4.50 EPS and FY2026 earnings at $21.00 EPS.

Several other research firms also recently commented on ALL. Wells Fargo & Company reduced their price target on shares of Allstate from $177.00 to $175.00 and set an “equal weight” rating for the company in a research report on Friday, August 16th. Piper Sandler upped their price objective on shares of Allstate from $188.00 to $196.00 and gave the stock an “overweight” rating in a research report on Friday, August 16th. JPMorgan Chase & Co. upped their price objective on shares of Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. Barclays upped their price objective on shares of Allstate from $175.00 to $187.00 and gave the stock an “underweight” rating in a research report on Thursday. Finally, TD Cowen upped their price objective on shares of Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research report on Tuesday, September 3rd. One research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $207.19.

Allstate Stock Down 1.3 %

ALL stock opened at $184.15 on Friday. The company has a fifty day moving average price of $188.87 and a 200 day moving average price of $175.23. Allstate has a 12 month low of $127.93 and a 12 month high of $198.79. The company has a market cap of $48.62 billion, a price-to-earnings ratio of 11.93, a price-to-earnings-growth ratio of 1.91 and a beta of 0.48. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 27.74%. The firm had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same quarter in the prior year, the firm earned $0.81 EPS. Allstate’s revenue for the quarter was up 14.7% on a year-over-year basis.

Insider Activity at Allstate

In related news, EVP Robert Toohey sold 16,682 shares of the stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $180.17, for a total value of $3,005,595.94. Following the sale, the executive vice president now directly owns 4,873 shares of the company’s stock, valued at approximately $877,968.41. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Robert Toohey sold 16,682 shares of the stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $180.17, for a total value of $3,005,595.94. Following the sale, the executive vice president now directly owns 4,873 shares of the company’s stock, valued at approximately $877,968.41. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider John E. Dugenske sold 36,367 shares of the stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 192,530 shares of company stock valued at $34,967,665. Insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On Allstate

Several hedge funds have recently modified their holdings of ALL. Northwest Investment Counselors LLC acquired a new stake in shares of Allstate during the 3rd quarter worth about $28,000. Catalyst Capital Advisors LLC acquired a new stake in shares of Allstate during the 3rd quarter worth about $29,000. Versant Capital Management Inc boosted its stake in shares of Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 78 shares during the last quarter. Family Firm Inc. acquired a new stake in shares of Allstate during the 2nd quarter worth about $38,000. Finally, MCF Advisors LLC boosted its stake in shares of Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares during the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.